As per Intent Market Research, the Nephrology And Urology Devices Market was valued at USD 16.7 Billion in 2024-e and will surpass USD 32.1 Billion by 2030; growing at a CAGR of 11.6% during 2025-2030.
The nephrology and urology devices market has experienced significant growth due to the rising global prevalence of kidney diseases, the aging population, and the increasing demand for minimally invasive procedures. The advancements in medical technologies such as robotic surgery, laser technologies, and endoscopy have played a crucial role in reshaping the treatment landscape for kidney and urological conditions. As a result, nephrology and urology devices have become indispensable in the management of chronic kidney disease (CKD), end-stage renal disease (ESRD), kidney stones, and other urological disorders. This market encompasses a wide array of devices, from dialysis equipment to diagnostic and therapeutic tools for stone management, all of which cater to patients' needs in both hospital and home care settings.
Dialysis Equipment Segment is Largest Owing to Growing CKD Prevalence
Dialysis equipment is the largest segment in the nephrology devices market, largely due to the increasing global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Dialysis is often the primary treatment option for patients whose kidneys can no longer perform their essential functions. With an aging population and lifestyle factors contributing to the rise in kidney diseases, the demand for dialysis machines, both for in-center and home dialysis, continues to surge. In particular, home dialysis equipment is gaining momentum due to the convenience it offers patients, especially in developed countries where access to healthcare is more readily available.
Technological advancements in dialysis equipment, such as improved filtration systems, portability, and patient comfort features, have further contributed to the growth of this segment. Companies are focusing on developing user-friendly dialysis systems that can be operated in home settings, reducing the burden on healthcare facilities. This trend is expected to continue driving growth in the dialysis equipment segment in the coming years.
Dialysis Centers Segment is Fastest Growing Owing to Increasing CKD Incidence
Dialysis centers represent the fastest growing segment in the end-user industry due to the rising incidence of chronic kidney disease (CKD) and the increasing number of patients requiring dialysis treatments. As CKD becomes more widespread, especially among elderly populations, the need for specialized dialysis centers equipped with advanced technologies and trained healthcare professionals continues to increase. These centers offer both hemodialysis and peritoneal dialysis, catering to patients who require continuous treatment for ESRD.
Dialysis centers are also becoming more sophisticated with the integration of telemedicine and remote monitoring, enabling patients to be closely monitored even when they are not in the clinic. This trend not only enhances patient outcomes but also reduces healthcare costs. As a result, dialysis centers are expected to see rapid expansion, particularly in emerging markets where healthcare infrastructure is developing, and the demand for specialized care is on the rise.
Laser Technology Segment is Fastest Growing Owing to Minimally Invasive Procedures
Laser technology is rapidly becoming the fastest growing segment in nephrology and urology devices, particularly due to its widespread use in kidney stone management and other urological procedures. Laser lithotripsy, which uses laser energy to break down kidney stones into smaller, passable fragments, is increasingly preferred for its minimally invasive nature, reduced recovery times, and better outcomes compared to traditional surgery. This technology has revolutionized stone treatment, allowing for the removal of stones without large incisions, leading to faster recovery and less postoperative pain for patients.
The growing preference for minimally invasive procedures in urology, especially in the treatment of kidney stones, prostate conditions, and urinary tract obstructions, further fuels the growth of laser technologies. As a result, laser technology is expected to dominate the urology market, with continued advancements in precision and effectiveness, offering patients safer alternatives with fewer complications.
Chronic Kidney Disease (CKD) Segment is Largest Owing to Global Prevalence
Chronic kidney disease (CKD) is the largest application in the nephrology and urology devices market, primarily driven by the increasing global burden of kidney diseases. Factors such as high blood pressure, diabetes, and an aging population have contributed to the rise in CKD cases. CKD can often progress to end-stage renal disease (ESRD) if left untreated, requiring the use of dialysis or kidney transplants. The growing demand for devices that aid in the diagnosis, management, and treatment of CKD, such as dialysis machines, kidney monitors, and urology instruments, further propels this segment.
The expansion of CKD treatment and management devices is also supported by increased awareness and earlier detection of kidney diseases. Health systems across the globe are focusing on improving CKD management through more effective treatments, which leads to greater utilization of nephrology devices for patient care.
North America Region is Largest Owing to Advanced Healthcare Infrastructure
North America remains the largest region for nephrology and urology devices, mainly due to its highly advanced healthcare infrastructure, early adoption of new technologies, and the high prevalence of kidney diseases, particularly in the United States. The rising incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the region has led to greater demand for dialysis treatments and other nephrology devices. Moreover, patients in North America benefit from advanced medical technologies, with healthcare systems offering extensive access to specialized treatments for kidney disorders.
The demand for both hospital-based and home dialysis equipment continues to rise in North America, with major healthcare providers focusing on improving patient outcomes and providing more personalized care options. The region’s large healthcare expenditure and investments in research and development ensure the continued dominance of North America in the global nephrology and urology devices market.
Competitive Landscape and Leading Companies
The nephrology and urology devices market is highly competitive, with several key players at the forefront of innovation. Leading companies in the market include Baxter International, Fresenius Medical Care, Medtronic, Johnson & Johnson, and Boston Scientific, among others. These companies are constantly involved in strategic partnerships, mergers and acquisitions, and product launches to strengthen their market presence. For instance, Fresenius Medical Care’s focus on expanding home dialysis solutions and Medtronic’s robotic surgery innovations are key drivers in the market’s competitive landscape.
The market is witnessing increasing consolidation, with both established players and emerging companies aiming to capitalize on the growing demand for advanced nephrology and urology devices. As competition intensifies, companies are investing heavily in research and development to create innovative solutions that cater to the evolving needs of healthcare professionals and patients. The emphasis is on enhancing device functionality, improving patient outcomes, and reducing the overall cost of treatment.
List of Leading Companies:
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Medtronic PLC
- Johnson & Johnson Services, Inc.
- Boston Scientific Corporation
- Stryker Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Siemens Healthineers
- ConvaTec Group PLC
- Cook Medical, Inc.
- Olympus Corporation
- Hologic Inc.
- Nephroplus
- Dialysis Clinic, Inc.
Recent Developments:
- Fresenius Medical Care launched a new home dialysis solution designed to improve patient quality of life and reduce hospital visits.
- Medtronic received regulatory approval for its new robotic-assisted surgery system for urology procedures in Europe.
- Baxter International introduced an updated version of its dialysis machine aimed at improving patient comfort and treatment outcomes.
- Boston Scientific expanded its urology portfolio with the acquisition of a leading innovator in minimally invasive treatments for prostate cancer.
- Johnson & Johnson announced a partnership with a digital health company to develop an AI-based system for early diagnosis of kidney diseases.
Report Scope:
Report Features |
Description |
Market Size (2024-e) |
USD 16.7 Billion |
Forecasted Value (2030) |
USD 32.1 Billion |
CAGR (2025 – 2030) |
11.6% |
Base Year for Estimation |
2024-e |
Historic Year |
2023 |
Forecast Period |
2025 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Global Nephrology and Urology Devices Market by Product Type (Dialysis Equipment, Kidney Stone Management Devices, Urology Endoscopes, Urinary Incontinence Devices), by End-User Industry (Hospitals, Dialysis Centers, Home Care Settings, Ambulatory Surgical Centers, Specialty Clinics), by Technology (Robotic Surgery, Laser Technology, Lithotripsy Technology, Endoscopy Technology), and by Application (Chronic Kidney Disease, End-Stage Renal Disease, Kidney Stones, Urinary Incontinence, Prostate Cancer Treatment); Global Insights & Forecast (2023 – 2030) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic PLC, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Stryker Corporation, B. Braun Melsungen AG, Terumo Corporation, Siemens Healthineers, ConvaTec Group PLC, Cook Medical, Inc., Olympus Corporation, Hologic Inc., Nephroplus, Dialysis Clinic, Inc. |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
Frequently Asked Questions
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Nephrology And Urology Devices Market, by Product Type (Market Size & Forecast: USD Million, 2023 – 2030) |
4.1. Dialysis Equipment |
4.2. Kidney Stone Management Devices |
4.3. Urology Endoscopes |
4.4. Urinary Incontinence Devices |
4.5. Others |
5. Nephrology And Urology Devices Market, by End-User Industry (Market Size & Forecast: USD Million, 2023 – 2030) |
5.1. Hospitals |
5.2. Dialysis Centers |
5.3. Home Care Settings |
5.4. Ambulatory Surgical Centers |
5.5. Specialty Clinics |
6. Nephrology And Urology Devices Market, by Technology (Market Size & Forecast: USD Million, 2023 – 2030) |
6.1. Robotic Surgery |
6.2. Laser Technology |
6.3. Lithotripsy Technology |
6.4. Endoscopy Technology |
6.5. Others |
7. Nephrology And Urology Devices Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
7.1. Chronic Kidney Disease (CKD) |
7.2. End-Stage Renal Disease (ESRD) |
7.3. Kidney Stones |
7.4. Urinary Incontinence |
7.5. Prostate Cancer Treatment |
7.6. Others |
8. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
8.1. Regional Overview |
8.2. North America |
8.2.1. Regional Trends & Growth Drivers |
8.2.2. Barriers & Challenges |
8.2.3. Opportunities |
8.2.4. Factor Impact Analysis |
8.2.5. Technology Trends |
8.2.6. North America Nephrology And Urology Devices Market, by Product Type |
8.2.7. North America Nephrology And Urology Devices Market, by End-User Industry |
8.2.8. North America Nephrology And Urology Devices Market, by Technology |
8.2.9. North America Nephrology And Urology Devices Market, by Application |
8.2.10. By Country |
8.2.10.1. US |
8.2.10.1.1. US Nephrology And Urology Devices Market, by Product Type |
8.2.10.1.2. US Nephrology And Urology Devices Market, by End-User Industry |
8.2.10.1.3. US Nephrology And Urology Devices Market, by Technology |
8.2.10.1.4. US Nephrology And Urology Devices Market, by Application |
8.2.10.2. Canada |
8.2.10.3. Mexico |
*Similar segmentation will be provided for each region and country |
8.3. Europe |
8.4. Asia-Pacific |
8.5. Latin America |
8.6. Middle East & Africa |
9. Competitive Landscape |
9.1. Overview of the Key Players |
9.2. Competitive Ecosystem |
9.2.1. Level of Fragmentation |
9.2.2. Market Consolidation |
9.2.3. Product Innovation |
9.3. Company Share Analysis |
9.4. Company Benchmarking Matrix |
9.4.1. Strategic Overview |
9.4.2. Product Innovations |
9.5. Start-up Ecosystem |
9.6. Strategic Competitive Insights/ Customer Imperatives |
9.7. ESG Matrix/ Sustainability Matrix |
9.8. Manufacturing Network |
9.8.1. Locations |
9.8.2. Supply Chain and Logistics |
9.8.3. Product Flexibility/Customization |
9.8.4. Digital Transformation and Connectivity |
9.8.5. Environmental and Regulatory Compliance |
9.9. Technology Readiness Level Matrix |
9.10. Technology Maturity Curve |
9.11. Buying Criteria |
10. Company Profiles |
10.1. Baxter International Inc. |
10.1.1. Company Overview |
10.1.2. Company Financials |
10.1.3. Product/Service Portfolio |
10.1.4. Recent Developments |
10.1.5. IMR Analysis |
*Similar information will be provided for other companies |
10.2. Fresenius Medical Care AG & Co. KGaA |
10.3. Medtronic PLC |
10.4. Johnson & Johnson Services, Inc. |
10.5. Boston Scientific Corporation |
10.6. Stryker Corporation |
10.7. B. Braun Melsungen AG |
10.8. Terumo Corporation |
10.9. Siemens Healthineers |
10.10. ConvaTec Group PLC |
10.11. Cook Medical, Inc. |
10.12. Olympus Corporation |
10.13. Hologic Inc. |
10.14. Nephroplus |
10.15. Dialysis Clinic, Inc. |
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Global Nephrology and Urology Devices Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Global Nephrology and Urology Devices Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Global Nephrology and Urology Devices Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.